Methylfolate (5-methyltetrahydrofolate) was administered to patients with thalassemia minor to pr... more Methylfolate (5-methyltetrahydrofolate) was administered to patients with thalassemia minor to prevent folate deficiency and its hematologic complications. Two groups of heterozygous beta-thalassemia patients were studied: 145 patients aged 14 to 40 years (mean, 30 ...
Methylfolate (5-methyltetrahydrofolate) was administered to patients with thalassemia minor to pr... more Methylfolate (5-methyltetrahydrofolate) was administered to patients with thalassemia minor to prevent folate deficiency and its hematologic complications. Two groups of heterozygous beta-thalassemia patients were studied: 145 patients aged 14 to 40 years (mean, 30 ...
Uploads
Papers